Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$974M |
| 2 |
JD.com
JD
|
+$620M |
| 3 |
FIGS
FIGS
|
+$559M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$447M |
| 5 |
GE Aerospace
GE
|
+$417M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$989M |
| 2 |
Microsoft
MSFT
|
+$981M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
AbCellera Biologics
ABCL
|
+$648M |
| 5 |
O'Reilly Automotive
ORLY
|
+$541M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.71% |
| 2 | Technology | 23.68% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zimmer Biomet
ZBH
$19.3B
| $475M | 1.44% |
3,042,796
-892,804
| -23% | -$145M |
|
27
Netflix
NFLX
$331B
| $464M | 1.41% |
8,785,440
+1,284,870
| +17% | +$65.7M |
|
28
Deere & Co
DE
$175B
| $454M | 1.38% |
1,287,395
+590,984
| +85% | +$216M |
|
29
Insulet
PODD
$10.3B
| $438M | 1.33% |
1,595,288
+559,324
| +54% | +$152M |
|
30
Avantor
AVTR
$9.78B
| $417M | 1.26% |
11,732,062
-3,775,826
| -24% | -$122M |
|
31
Ameriprise Financial
AMP
$49.1B
| $383M | 1.16% |
1,539,788
+692,061
| +82% | +$174M |
|
32
Match Group
MTCH
$9.38B
| $380M | 1.15% |
2,356,406
+321,930
| +16% | +$47.2M |
|
33
Labcorp
LH
$27.3B
| $379M | 1.15% |
1,598,654
+340,115
| +27% | +$77.5M |
|
34
Assurant
AIZ
$14B
| $377M | 1.14% |
2,411,046
-365,054
| -13% | -$57M |
|
35
ICICI Bank
IBN
$107B
| $360M | 1.09% |
+21,070,884
| New | +$351M |
|
36
Ingersoll Rand
IR
$31.2B
| $313M | 0.95% |
6,417,254
+1,046,942
| +19% | +$51.4M |
|
|
37
Bank of America
BAC
$431B
| $296M | 0.9% |
7,174,216
-24,138,200
| -77% | -$989M |
|
|
MRSH
38
Marsh
MRSH
$91.6B
| $289M | 0.88% |
2,057,461
-24,426
| -1% | -$3.28M |
|
39
Lithia Motors
LAD
$8.15B
| $277M | 0.84% |
807,493
+482,112
| +148% | +$174M |
|
40
Zai Lab
ZLAB
$2.92B
| $272M | 0.83% |
1,539,257
+796,240
| +107% | +$128M |
|
41
Humana
HUM
$45.5B
| $260M | 0.79% |
+588,285
| New | +$257M |
|
42
Sunrun
RUN
$2.21B
| $249M | 0.76% |
4,464,114
+67,946
| +2% | +$3.28M |
|
43
Align Technology
ALGN
$11.5B
| $247M | 0.75% |
404,087
-140,594
| -26% | -$83.2M |
|
44
Molina Healthcare
MOH
$10.5B
| $246M | 0.75% |
973,356
-460,397
| -32% | -$116M |
|
45
Brookfield
BN
$93.1B
| $211M | 0.64% |
+7,664,345
| New | +$196M |
|
46
Parker-Hannifin
PH
$126B
| $205M | 0.62% |
666,117
-152,067
| -19% | -$47.1M |
|
47
Booking.com
BKNG
$158B
| $197M | 0.6% |
+2,252,325
| New | +$210M |
|
|
XYZ
48
Block Inc
XYZ
$49.4B
| $160M | 0.48% |
+655,437
| New | +$152M |
|
49
Intellia Therapeutics
NTLA
$1.8B
| $158M | 0.48% |
+975,092
| New | +$75.9M |
|
50
Tenet Healthcare
THC
$22.6B
| $153M | 0.46% |
2,279,182
+817,869
| +56% | +$50.7M |
|
Similar funds
Andreas Halvorsen's Q2 2021 Portfolio in Review
As of Q2 2021, Andreas Halvorsen held 117 positions worth $33B, down 1.8% from $33.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Andreas Halvorsen withdrew a net $2.78B in Q2 2021, closing 29 positions and reducing 29 holdings. Its most notable exit was AbCellera Biologics, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
Against the trend, Andreas Halvorsen opened a new position in JD.com worth $658M.
- Andreas Halvorsen's largest Q2 2021 buy was JD.com: 8,241,079 shares worth $658M.
- Andreas Halvorsen added most to Amazon in Q2 2021, an estimated $974M increase.
- Andreas Halvorsen's biggest Q2 2021 reduction was Bank of America, cutting an estimated $989M.
- Andreas Halvorsen fully exited AbCellera Biologics in Q2 2021, selling an estimated $648M.
- Andreas Halvorsen's ten largest holdings make up 37% of its $33B portfolio in Q2 2021.
- Andreas Halvorsen opened 22 new positions and closed 29 in Q2 2021.
- Andreas Halvorsen's portfolio value fell 1.8% quarter-over-quarter to $33B.
Based on Viking Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.